Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 December 2020
Health sciences
The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic. The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on Monday due to COVID-19.

The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic.

The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on 14 December due to COVID-19. Another virtual graduation is scheduled for 4 January 2021.

An uncomfortable reality
Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at the UFS, congratulated the latest UFS doctors on their success. Said Dr Van der Merwe: “In a tumultuous year dominated by the COVID-19 pandemic, this group of final-year medical students refused to give in to the pressure and disruption of national lockdown, emergency remote teaching, an adjusted academic calendar, and frontline exposure as healthcare professionals in training.”  

“They persevered against all odds, faced up to an uncomfortable reality, and showed remarkable resilience.”

According to Dr Van der Merwe, the class of 2020 completed the gruelling five-year medical programme with a pass rate of 98,3%, impressing external examiners who commented on their respectful attitude towards patients and thorough knowledge and skill.  

“The School of Clinical Medicine and Faculty of Health Sciences are immensely proud of our new colleagues and look forward to their contribution to the future of healthcare in South Africa. This achievement would not have been possible without the unwavering commitment of the academic and support staff who guided our students and led the way for them to achieve a life-long dream.”  

“We look back with gratitude on a year that required more than the usual amount of adaptability, creativity, innovation, faith, patience, bravery, and endurance.  It is these qualities that set apart the doctors who graduate from the UFS, and those who train them,” says Dr Van der Merwe.

Hope for the future
She says while COVID-19 is still a harsh reality and the future holds much uncertainty, 2020 has shown that there is hope when we face challenges with grace under pressure, and a firm belief in our goals and values. “Class of 2020, may you continue to rise above fear, chaos and disappointment, may you take heart and walk your journey with strength, may you bring healing to our people and lead us well.”

Drs Kaamilah Joosub and Lynette Upman, who also graduated on Monday, were awarded the prestigious Bongani Mayosi Medical Students Academic Prize – a national award which aims to recognise final-year medical students who epitomise the academic, legendary, and altruistic life of the late Prof Mayosi. The awards are presented to final-year MB ChB students from all South African medical faculties. This is the first year it has been awarded.

View the virtual graduation

News Archive

UFS receives R13,7 Million for Research into Prehistoric Organisms
2007-03-27

Some of the guests attending the launch of the research contract are: Dr Siyabulela Ntutela (Deputy Director: Biotechnology at the Department of Science and Technology), Dr Godfrey Netswera (Manager of Thuthuka and the Support Programme at the National Research Foundation (NRF)), Dr Esta van Heerden (Platform Manager and lecturer at the Department of Microbial, Biochemical and Food Biotechnology at the UFS), Mr Butana Mboniswa (Chief Executive Officer of BioPAD), and Mr Vuyisele Phehani (Portfolio Manager for BioPAD).
Photo: Leonie Bolleurs

The University of the Free State (UFS) has been awarded a massive R13,7 million contract to conduct research into prehistoric micro-organisms which live under extreme conditions, for example in mineshafts.

This is one of the biggest research contracts awarded to the UFS in recent years.

The biotechnology research contract was awarded to the UFS by BioPAD, a South African biotechnology company that brokers partnerships between researchers, entrepreneurs, business, government and other stakeholders to promote innovation and create sustainable biotechnology businesses.

The project is endorsed by the Department of Science and Technology and the National Research Foundation (NRF), which contributes to the bursaries of the 17 postgraduate students on the programme.

The contract involves the establishment of a Platform for Metagenomics -  a technique which allows researchers to extract the DNA from microbes in their natural environment and investigate it in a laboratory. 

“Through this platform we will be able to understand deepmine microbial populations
and their potential application in the search for life in outer space.  It is most likely
that, if life were to be found on other planets in our solar system, it would probably
resemble that which existed millions of years ago on earth.  Apart from all this, these
organisms have unique properties one can exploit in biotechnological application for
South Africa and its community,” said Dr Esta van Heerden, platform manager and
lecturer at the UFS Department of Microbial, Biochemical and Food Biotechnology.
She is assisted by her collegues, Prof. Derek Litthauer and Dr Lizelle Piater.

“The platform aims to tap into the unique genetic material in South African mines
which will lead to the discovery of new genes and their products.  These new and unique products will find application in the medical field (anti-cancer, anti-bacterial en anti-viral cures), the industrial sector (nanotechnology, commercial washing agents and the food industry), environmental sector (pollution management, demolition of harmful metals and other toxic waste),” said Dr Van Heerden.

According to Dr Van Heerden, the Metagenomics Platforms stems from the Life in
Extreme Environments (LExEN) programme which was started in 1994 by Princeton
University in the United States of America (USA) in South African mines with grants
from among others the National Aeronautics and Space Administration (NASA) and
the National Science Foundation (NSF) in the USA.  Other international collaborators
on the project include Geosynec Consultants Inc. (USA), Oak Ridge National
Laboratory (USA), the University of Tennessee (USA) and in South Africa the
Universities of the Witwatersrand, North West and Limpopo and companies like BHP
Billiton, MINTEK and mining companies like Harmony, Gold Fields and AngloGold
Ashanti.

The research field laboratory of the Metagenomics Platform, which was situated in
Glen Harvey, was moved to the Main Campus of the UFS in Bloemfontein.  “In this
way the university has become the central hub for all research programmes.  We are
also the liaison between the LExEN programme and the various mining companies
involved,” said Dr Van Heerden.  The new laboratory was introduced during the
launch of the research contract.

“Our decision to commit BioPAD to this project stems from the company’s commitment to advance human capacity development to strengthen South Africa’s research infrastructure.  It is also part of our aim to create and protect intellectual property,” said Mr Butana Mboniswa, Chief Executive Officer of BioPAD.

Talking on behalf of the UFS senior management, Prof. Teuns Verschoor, Vice-Rector
of Academic Operations, said that the university shares the excitement to be part of
the exploration of unknown forms of life, the discovery of new genes and
their products and in applying newly gained knowledge to better understand our
universe.

Media release
Issued by: Lacea Loader
Assistant Director: Media Liaison 
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za
27 March 2007

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept